Skip to main content
TipRanks
Go Ultimate75% OFF

Biosyent (RX) Revenue

56 Followers

Biosyent Revenue

Biosyent had a revenue of 19.87M in the quarter ending Jun 30, 2026, with 42.89%. This bring the company's revenue in the last twelve months to 55.67M, Increased 21.08%. In the fiscal year ending Dec 31, 2025, Biosyent had annual revenue of 43.05M with 22.90% growth.

Revenue (ttm)
55.67M
Revenue Growth
40.91%
P/S Ratio
4.67
Revenue/Employee
CAD 717,533
Employees
60
Market Cap
CAD 201.18M

Revenue Chart

Biosyent Revenue - Annual

010M20M30M40M50M20.76M21.53M21.42M22.33M28.62M27.93M31.59M35.03M43.05M201720182019202020212022202320242025
Revenue History
Download to Excel
TSE:RX revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202543.05M8.02M22.90%
Dec 31, 202435.03M3.44M10.89%
Dec 31, 202331.59M3.67M13.12%
Dec 31, 202227.93M-693.03K-2.42%
Dec 31, 202128.62M6.29M28.15%
Dec 31, 202022.33M907.84K4.24%
Dec 31, 201921.42M-102.70K-0.48%
Dec 31, 201821.53M764.27K3.68%
Dec 31, 201720.76M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
TSE:RX55.67M
TSE:AQS815.03K
TSE:ATLE―
TSE:MDP107.93M
TSE:HLS56.66M
TSE:CRDL0.00